Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Morin

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Journal of Psychosomatic Research|May 4, 2005
Family studies in insomniaYves Dauvilliers, Charles Morin, Katerina Cervena, et al.
The Journal of Pediatrics|May 29, 2017
ReplyChiraz Ghaddhab, Charles Morin, Catherine Brunel-Guitton, et al.
The Journal of Pediatrics|March 13, 2017
Premature Ovarian Failure in French Canadian Leigh SyndromeChiraz Ghaddhab, Charles Morin, Catherine Brunel-Guitton, et al.
International Journal of Molecular Sciences|September 14, 2024
Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic PerspectivesMbarka Bchetnia, Julie Powell, Catherine McCuaig, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 29, 2011
Low-concentration methylene blue maintains energy production and strongly improves survival of Leigh syndrome French Canadian skin fibroblastsJean Legault, Pierre-Luc Larouche, Isabelle Côté, et al.
Plos One|April 4, 2015
Mitochondrial vulnerability and increased susceptibility to nutrient-induced cytotoxicity in fibroblasts from leigh syndrome French canadian patientsYan Burelle, Chantal Bemeur, Marie-Eve Rivard, et al.
Stem Cell Research|March 25, 2022
Generation of two induced pluripotent stem cell lines (UQACi002-A and UQACi005-A) from two patients with KRT14 epidermolysis bullosa simplex mutationsMbarka Bchetnia, Laurie Martineau, Véronique Racine, et al.
Stem Cell Research|March 5, 2022
Generation of three induced pluripotent stem cell lines (UQACi003-A, UQACi004-A, and UQACi006-A) from three patients with KRT5 epidermolysis bullosa simplex mutationsMbarka Bchetnia, Laurie Martineau, Véronique Racine, et al.
The CRISPR Journal|July 21, 2022
Allele-Specific Inactivation of an Autosomal Dominant Epidermolysis Bullosa Simplex Mutation Using CRISPR-Cas9Mbarka Bchetnia, Rebecca Dionne Gagné, Julie Powell, et al.
Human Genetics|August 31, 2011
Expression signature of epidermolysis bullosa simplexMbarka Bchetnia, Marie-Lou Tremblay, Georgette Leclerc, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Journal of Psychosomatic Research|May 4, 2005
Family studies in insomniaYves Dauvilliers, Charles Morin, Katerina Cervena, et al.
The Journal of Pediatrics|May 29, 2017
ReplyChiraz Ghaddhab, Charles Morin, Catherine Brunel-Guitton, et al.
The Journal of Pediatrics|March 13, 2017
Premature Ovarian Failure in French Canadian Leigh SyndromeChiraz Ghaddhab, Charles Morin, Catherine Brunel-Guitton, et al.
International Journal of Molecular Sciences|September 14, 2024
Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic PerspectivesMbarka Bchetnia, Julie Powell, Catherine McCuaig, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 29, 2011
Low-concentration methylene blue maintains energy production and strongly improves survival of Leigh syndrome French Canadian skin fibroblastsJean Legault, Pierre-Luc Larouche, Isabelle Côté, et al.
Plos One|April 4, 2015
Mitochondrial vulnerability and increased susceptibility to nutrient-induced cytotoxicity in fibroblasts from leigh syndrome French canadian patientsYan Burelle, Chantal Bemeur, Marie-Eve Rivard, et al.
Stem Cell Research|March 25, 2022
Generation of two induced pluripotent stem cell lines (UQACi002-A and UQACi005-A) from two patients with KRT14 epidermolysis bullosa simplex mutationsMbarka Bchetnia, Laurie Martineau, Véronique Racine, et al.
Stem Cell Research|March 5, 2022
Generation of three induced pluripotent stem cell lines (UQACi003-A, UQACi004-A, and UQACi006-A) from three patients with KRT5 epidermolysis bullosa simplex mutationsMbarka Bchetnia, Laurie Martineau, Véronique Racine, et al.
The CRISPR Journal|July 21, 2022
Allele-Specific Inactivation of an Autosomal Dominant Epidermolysis Bullosa Simplex Mutation Using CRISPR-Cas9Mbarka Bchetnia, Rebecca Dionne Gagné, Julie Powell, et al.
Human Genetics|August 31, 2011
Expression signature of epidermolysis bullosa simplexMbarka Bchetnia, Marie-Lou Tremblay, Georgette Leclerc, et al.
Pageof 5